FrancophonIA/ELRC3.0 huggingface dataset:
English: Patients should be monitored closely to ensure that the lowest approved dose of Abseamed is used to provide adequate control of anaemia and of the symptoms of anaemia.
Spanish: Se debe vigilar estrechamente a los pacientes con el fin de asegurar que se emplea la dosis mínima aprobada de Abseamed para proporcionar un control adecuado de los síntomas de la anemia.
English: Abseamed should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L).
Spanish: Abseamed debe administrarse a fin de aumentar la hemoglobina a una concentración no superior a 11 g/dl (6,8 mmol/l).
English: If you visit a hospital, clinic or family doctor, tell them you are having Abseamed treatment.
Spanish: Si visita un hospital, clínica o médico de cabecera, dígales que recibe tratamiento con Abseamed, ya que puede afectar a otros tratamientos o resultados de análisis.
English: INFORMATION IN BRAILLE Abseamed 40,000 IU/1 mL
Spanish: INFORMACIÓN EN BRAILLE Abseamed 40.000 UI/1 ml
English: INFORMATION IN BRAILLE Abseamed 20,000 IU/0.5 mL
Spanish: INFORMACIÓN EN BRAILLE Abseamed 20.000 UI/0,5 ml
English: Abseamed contains sodium
Spanish: Abseamed contiene sodio:
English: If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Abseamed dose by about 25 to 50%.
Spanish: Si la concentración de hemoglobina aumenta más de 2 g/dl (1,25 mmol/l) al mes, o si el nivel de concentración de hemoglobina es superior a 12 g/dl (7,5 mmol/l), reduzca la dosis de Abseamed en alrededor de un 25 a un 50%.
English: Abseamed is one of a group of products that stimulate the production of red blood cells like the human protein erythropoietin does.
Spanish: Tenga especial cuidado con otros productos que estimulan la producción de glóbulos rojos: Abseamed es un producto perteneciente a un grupo de productos que estimulan la producción de glóbulos rojos al igual que la eritropoyetina, que es una proteína humana.
English: Abseamed should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Spanish: Abseamed se debe administrar a pacientes con anemia sintomática (p. ej., concentración de hemoglobina ≤10 g/dl [6,2 mmol/l]).
English: Abseamed should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)).
Spanish: Abseamed debe administrarse a los pacientes con anemia (por ejemplo, concentración de hemoglobina ≤ 10 g/dl (6,2 mmol/l)).
English: While on Abseamed, some people need medicines to reduce the risk of blood clots.
Spanish: Algunas personas necesitan medicamentos para reducir el riesgo de que se formen coágulos de sangre durante el tratamiento con Abseamed.
English: Abseamed should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L).
Spanish: Abseamed debe administrarse a fin de aumentar la hemoglobina a una concentración no superior a 12 g/dl (7,5 mmol/l).
English: If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Abseamed therapy at a dose 25% below the previous dose.
Spanish: Si el nivel de concentración de hemoglobina es superior a 13 g/dl (8,1 mmol/l), interrumpa el tratamiento hasta que descienda por debajo de 12 g/dl (7,5 mmol/l) y después, reinicie el tratamiento con Abseamed a una dosis un 25% inferior a la dosis anterior.
English: If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Abseamed dose by 25%.
Spanish: Si la hemoglobina aumenta más de 2 g/dl (1,25 mmol/l) al mes o si la hemoglobina prolongada es superior a 12 g/dl (7,5 mmol/l), se debe reducir un 25% la dosis de Abseamed.
English: If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Abseamed therapy at a dose 25% below the previous dose.
Spanish: Si la hemoglobina es superior a 13 g/dl (8,1 mmol/l), se debe suspender el tratamiento hasta que descienda a menos de 12 g/dl (7,5 mmol/l) y, luego, se debe reiniciar el tratamiento con Abseamed a una dosis un 25% inferior a la dosis anterior.
English: In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Abseamed by the intravenous route is preferable.
Spanish: En los pacientes pediátricos con insuficiencia renal crónica en los que se pueda conseguir de forma sistemática un acceso intravenoso (pacientes en hemodiálisis), es preferible administrar Abseamed por vía intravenosa.
English: In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Abseamed by the intravenous route is preferable.
Spanish: En los pacientes con insuficiencia renal crónica en los que se pueda conseguir de forma sistemática un acceso intravenoso (pacientes en hemodiálisis), es preferible administrar Abseamed por vía intravenosa.
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa
Spanish: Abseamed 30.000 UI/0,75 ml solución inyectable en una jeringa precargada Epoetina alfa
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection.
Spanish: Abseamed 8.000 UI/0,8 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,8 ml solución inyectable.
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 8.000 UI/0,8 ml solución inyectable en una jeringa precargada
English: INFORMATION IN BRAILLE Abseamed 8,000 IU/0.8 mL
Spanish: Abseamed 8.000 UI/0,8 ml
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection.
Spanish: Abseamed 30.000 UI/0,75 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,75 ml solución inyectable.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 8,000 IU/0.8 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 8.000 UI/0,8 ml inyectable Epoetina alfa
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/013
Spanish: Abseamed 8.000 UI/0,8 ml solución inyectable en una jeringa precargada EU/1/07/412/013
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Spanish: Abseamed 7.000 UI/0,7 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,7 ml solución inyectable.
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 9.000 UI/0,9 ml solución inyectable en una jeringa precargada
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 7.000 UI/0,7 ml solución inyectable en una jeringa precargada
English: INFORMATION IN BRAILLE Abseamed 7,000 IU/0.7 mL
Spanish: Abseamed 7.000 UI/0,7 ml
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Spanish: Abseamed 9.000 UI/0,9 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,9 ml solución inyectable.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 6.000 UI/0,6 ml solución inyectable en una jeringa precargada
English: INFORMATION IN BRAILLE Abseamed 9,000 IU/0.9 mL
Spanish: Abseamed 9.000 UI/0,9 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 9,000 IU/0.9 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 9.000 UI/0,9 ml inyectable Epoetina alfa
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 40,000 IU/1 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 40.000 UI/1 ml inyectable
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 30,000 IU/0.75 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 30.000 UI/0,75 ml inyectable Epoetina alfa
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023
Spanish: Abseamed 30.000 UI/0,75 ml solución inyectable en una jeringa precargada EU/1/07/412/023
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 6,000 IU/0.6 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 6.000 UI/0,6 ml inyectable Epoetina alfa
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Spanish: Abseamed 40.000 UI/1 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 40.000 UI de epoetina alfa,* que corresponde a 336,0 microgramos por ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 2,000 IU/1 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 2.000 UI/1 ml inyectable
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Spanish: Abseamed 4.000 UI/0,4 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,4 ml solución inyectable.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Spanish: Abseamed 6.000 UI/0,6 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,6 ml solución inyectable.
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 4.000 UI/0,4 ml solución inyectable en una jeringa precargada
English: INFORMATION IN BRAILLE Abseamed 6,000 IU/0.6 mL
Spanish: Abseamed 6.000 UI/0,6 ml
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Spanish: Abseamed 30.000 UI/0,75 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 40.000 UI de epoetina alfa,* que corresponde a 336,0 microgramos por ml
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/412/011
Spanish: Abseamed 6.000 UI/0,6 ml solución inyectable en una jeringa precargada EU/1/07/412/011
English: INFORMATION IN BRAILLE Abseamed 30,000 IU/0.75 mL
Spanish: Abseamed 30.000 UI/0,75 ml
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/412/019
Spanish: Abseamed 9.000 UI/0,9 ml solución inyectable en una jeringa precargada EU/1/07/412/019
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 10,000 IU/1 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 10.000 UI/1 ml inyectable
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/021
Spanish: Abseamed 20.000 UI/0,5 ml solución inyectable en una jeringa precargada EU/1/07/412/021
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Spanish: Abseamed 20.000 UI/0,5 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 40.000 UI de epoetina alfa,* que corresponde a 336,0 microgramos por ml
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/009
Spanish: Abseamed 5.000 UI/0,5 ml solución inyectable en una jeringa precargada EU/1/07/412/009
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 20.000 UI/0,5 ml solución inyectable en una jeringa precargada
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/003
Spanish: Abseamed 2.000 UI/1 ml solución inyectable en una jeringa precargada EU/1/07/412/003
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 4,000 IU/0.4 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 4.000 UI/0,4 ml inyectable Epoetina alfa
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 5.000 UI/0,5 ml solución inyectable en una jeringa precargada
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 3,000 IU/0.3 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 3.000 UI/0,3 ml inyectable Epoetina alfa
English: What is in this leaflet What Abseamed is and what it is used for What you need to know before you use Abseamed How to use Abseamed Possible side effects How to store Abseamed Contents of the pack and other information What Abseamed is and what it is used for Abseamed contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Spanish: Abseamed contiene el principio activo epoetina alfa, una proteína que estimula a la médula ósea para que produzca más glóbulos rojos, que llevan la hemoglobina (una sustancia que transporta oxígeno).
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 7,000 IU/0.7 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 7.000 UI/0,7 ml inyectable Epoetina alfa
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/412/007
Spanish: Abseamed 4.000 UI/0,4 ml solución inyectable en una jeringa precargada EU/1/07/412/007
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/025
Spanish: Abseamed 40.000 UI/1 ml solución inyectable en una jeringa precargada EU/1/07/412/025
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Spanish: Abseamed 20.000 UI/0,5 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,5 ml solución inyectable.
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/412/005
Spanish: Abseamed 3.000 UI/0,3 ml solución inyectable en una jeringa precargada EU/1/07/412/005
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 5.000 UI/0,5 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection.
Spanish: Abseamed 3.000 UI/0,3 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,3 ml solución inyectable.
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 3.000 UI/0,3 ml solución inyectable en una jeringa precargada
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 5,000 IU/0.5 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 5.000 UI/0,5 ml inyectable Epoetina alfa
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Spanish: Abseamed 5.000 UI/0,5 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,5 ml solución inyectable.
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/412/017
Spanish: Abseamed 7.000 UI/0,7 ml solución inyectable en una jeringa precargada EU/1/07/412/017
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 20,000 IU/0.5 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 20.000 UI/0,5 ml inyectable Epoetina alfa
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 40.000 UI/1 ml solución inyectable en una jeringa precargada
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Spanish: Abseamed 40.000 UI/1 ml solución inyectable en una jeringa precargada Cada jeringa contiene 1 ml solución inyectable.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 2.000 UI/1 ml solución inyectable en una jeringa precargada
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Spanish: Abseamed 2.000 UI/1 ml solución inyectable en una jeringa precargada Cada jeringa contiene 1 ml solución inyectable.
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 1.000 UI/0,5 ml solución inyectable en una jeringa precargada
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 8.000 UI/0,8 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: INFORMATION IN BRAILLE Abseamed 4,000 IU/0.4 mL
Spanish: Abseamed 4.000 UI/0,4 ml
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 7.000 UI/0,7 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: Breast-feeding
Spanish: Composición de Abseamed
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Spanish: Abseamed 2.000 UI/1 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 2.000 UI de epoetina alfa,* que corresponde a 16,8 microgramos por ml Una jeringa precargada de 1 ml contiene 2.000 unidades internacionales (UI) y corresponde a 16,8 microgramos de epoetina alfa*.
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Spanish: Abseamed 10.000 UI/1 ml solución inyectable en una jeringa precargada Cada jeringa contiene 1 ml solución inyectable.
English: INFORMATION IN BRAILLE Abseamed 5,000 IU/0.5 mL
Spanish: Abseamed 5.000 UI/0,5 ml
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/015
Spanish: Abseamed 10.000 UI/1 ml solución inyectable en una jeringa precargada EU/1/07/412/015
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe
Spanish: Abseamed 10.000 UI/1 ml solución inyectable en una jeringa precargada
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/001
Spanish: Abseamed 1.000 UI/0,5 ml solución inyectable en una jeringa precargada EU/1/07/412/001
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 9.000 UI/0,9 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 1,000 IU/0.5 mL injection
Spanish: NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN Abseamed 1.000 UI/0,5 ml inyectable Epoetina alfa
English: INFORMATION IN BRAILLE Abseamed 3,000 IU/0.3 mL
Spanish: Abseamed 3.000 UI/0,3 ml
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 4.000 UI/0,4 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Spanish: Abseamed 1.000 UI/0,5 ml solución inyectable en una jeringa precargada Cada jeringa contiene 0,5 ml solución inyectable.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 6.000 UI/0,6 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 3.000 UI/0,3 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Spanish: Abseamed 10.000 UI/1 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 10.000 UI de epoetina alfa,* que corresponde a 84,0 microgramos por ml
English: INFORMATION IN BRAILLE Abseamed 2,000 IU/1 mL
Spanish: Abseamed 2.000 UI/1 ml
English: How to store Abseamed
Spanish: Conservación de Abseamed
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Spanish: Abseamed 1.000 UI/0,5 ml solución inyectable en una jeringa precargada Cada ml de solución contiene 2.000 UI de epoetina alfa,* que corresponde a 16,8 microgramos por ml Una jeringa precargada de 0,5 ml contiene 1.000 unidades internacionales (UI) y corresponde a 8,4 microgramos de epoetina alfa*.
English: INFORMATION IN BRAILLE Abseamed 10,000 IU/1 mL
Spanish: Abseamed 10.000 UI/1 ml
English: The fate of the remainder is undetermined.
Spanish: El destino del resto no está determinado.
English: The patients were between 22 months and 72 years old.
Spanish: Los pacientes tenían entre 22 meses y 72 años de edad.
English: May cause birth defects.
Spanish: Puede causar defectos de nacimiento.
English: This medicinal product should not be used any further.
Spanish: Este medicamento ya no se debe utilizar.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/ema/.
Spanish: La información detallada de este medicamento está disponible en la página web de la Agencia Europea de Medicamentos: http://www.ema.europa.eu/ema/.
English: These may be signs of a severe allergic reaction.
Spanish: Pueden ser signos de una reacción alérgica grave.
English: The following schedule is suggested as a guide to dosage adjustment:
Spanish: Se sugiere el siguiente esquema como guía para el ajuste de la dosis:
English: The duration of the treatment is determined by the doctor and may vary for each patient.
Spanish: La duración del tratamiento será determinada por el médico y podrá variar en cada paciente.
English: Harmful for those suffering from alcoholism.
Spanish: Perjudicial para las personas que padecen alcoholismo.
English: Carmustine Obvius may cause the following side effects:
Spanish: Carmustina Obvius puede causar los siguientes efectos adversos:
English: 1081 CN Amsterdam The Netherlands
Spanish: 1081 CN Amsterdam Países Bajos
English: This medicine will be stored by your doctor or health care professional.
Spanish: Este medicamento será conservado por su médico o profesional sanitario.